Literature DB >> 15705277

The outcome of oropharyngeal gonorrhoea treatment with different regimens.

K Manavi1, H Young, A McMillan.   

Abstract

Little is known of the efficacy of different antibiotics for the treatment of oropharyngeal gonorrhoea in routine clinical practice. The aim of the study was to investigate the treatment outcome of oropharyngeal gonorrhoea with different antibiotics. Case-notes of culturally proven oropharyngeal gonorrhoea diagnosed between January 1998 and January 2003 were reviewed for the antibiotic of choice and the result of test-of-cure (TOC) seven and 14 days after treatment. Of 117 episodes of pharyngeal gonorrhoea, 77 episodes (66%) were followed up with one TOC and 25 (21%) had two TOC. Treatment failure was recorded in 10% (8/77) of episodes: the failure rate was 28% (4/14) in patients treated with amoxicillin 3 g/probenecid 1 g stat and 11% (4/35) in those treated with ciprofloxacin 500 mg stat. The failure rate in treating pharyngeal gonorrhoea supports the need for a pharyngeal TOC culture as part of routine follow-up for patients infected at this site. As only 66% of patients had a TOC culture, efforts should be made to increase the number of patients having a TOC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15705277     DOI: 10.1258/0956462052932566

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  5 in total

1.  [Sexually transmitted infections of the oral cavity].

Authors:  H Schöfer
Journal:  Hautarzt       Date:  2012-09       Impact factor: 0.751

Review 2.  The use of cephalosporins for gonorrhea: the impending problem of resistance.

Authors:  Pennan M Barry; Jeffrey D Klausner
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

3.  Extragenital manifestations of Neisseria gonorrhoeae.

Authors:  Steven E Spencer; Margaret C Bash
Journal:  Curr Infect Dis Rep       Date:  2006-03       Impact factor: 3.725

4.  An open-label, parallel-group, randomised controlled trial of antiseptic mouthwash versus antibiotics for oropharyngeal gonorrhoea treatment (OMEGA2).

Authors:  Eric P F Chow; Kate Maddaford; Jane S Hocking; Catriona S Bradshaw; Rebecca Wigan; Marcus Y Chen; Benjamin P Howden; Deborah A Williamson; Christopher K Fairley
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

Review 5.  Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature.

Authors:  Philip A Chan; Ashley Robinette; Madeline Montgomery; Alexi Almonte; Susan Cu-Uvin; John R Lonks; Kimberle C Chapin; Erna M Kojic; Erica J Hardy
Journal:  Infect Dis Obstet Gynecol       Date:  2016-06-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.